Poly-l-Lactic Acid as a Regenerative Treatment for the Glucagon-like Peptide-1 Receptor Agonist User Population
Open Access
- 18 May 2026
- journal article
- review article
- Published by Wolters Kluwer Health in Dermatologic Surgery
- Vol. 52 (6S) , S10-S15
Abstract
BACKGROUND: Glucagon-like peptide-1 (GLP-1) receptor agonists (RAs) used for weight management have introduced unintended facial changes only partially addressed by conventional volumizing fillers. OBJECTIVE: Evaluate the mechanistic rationale and clinical evidence supporting poly- l -lactic acid Sculptra (PLLA-SCA) as a biostimulatory and regenerative treatment for GLP-1 RA–associated facial changes. METHODS: This narrative review synthesizes mechanistic and clinical data alongside expert opinion regarding PLLA-SCA for GLP-1 RA–driven weight loss, focusing on its biostimulatory and regenerative effects across skin layers. RESULTS: Poly- l -lactic acid Sculptra induces fibroblast recruitment and stimulates regeneration of collagen and elastin, and effects vasculature and adipose tissue, resulting in durable improvements in skin quality, elasticity, facial contour, and perceived age that persist for 2 years or longer. Clinical studies and real-world experiences demonstrate clinically meaningful corrections of midface and perioral volume loss, jawline contour, and radiance, including in patients with GLP-1 RA–related facial changes. CONCLUSION: Poly- l -lactic acid Sculptra may help address GLP-1 RA–associated facial atrophy by supporting long-term regeneration and restoration of facial definition, contour, and skin quality. The effects potentially extend across all 3 skin layers affected by the GLP-1 RA phenotype, including atrophy and gauntness. Poly-L-lactic acid Sculptra offers clinicians an option to deliver durable regenerative treatment that helps restore facial aesthetics in this patient population.Keywords
This publication has 23 references indexed in Scilit:
- A Multicenter, Open-Label Study of Combined Poly-L-Lactic Acid and Hyaluronic Midface Filler Regimen Enhances Facial Harmony and Skin Quality in GLP-1 Medication UsersAesthetic Surgery Journal, 2025
- Efficacy, Durability, and Safety of Collagen Biostimulators Based on Poly-L-Lactic Acid (PLLA) and Calcium Hydroxyapatite (CaHA) in the Face: A Systematic ReviewAesthetic Plastic Surgery, 2025
- A Systematic Review on the Effectiveness and Safety of Combining Biostimulators with Botulinum Toxin, Dermal Fillers, and Energy-Based DevicesAesthetic Plastic Surgery, 2024
- Adipose Tissue, Regeneration, and Skin Health: The Next Regenerative FrontierAesthetic Surgery Journal Open Forum, 2024
- Soft Tissue Facial Changes Following Massive Weight Loss Secondary to Medical and Surgical Bariatric Interventions: A Systematic ReviewAesthetic Surgery Journal Open Forum, 2024
- Implications of Ozempic and Other GLP-1 Receptor Agonists for Facial Plastic SurgeonsFacial Plastic Surgery, 2023
- Clinical Relevance of Elastin in the Structure and Function of SkinAesthetic Surgery Journal Open Forum, 2021
- Objective Assessment of Facial Rejuvenation After Massive Weight LossAesthetic Plastic Surgery, 2015
- Poly (Lactic Acid) Production for Tissue Engineering ApplicationsProcedia Engineering, 2012
- A randomized study of the efficacy and safety of injectable poly-L-lactic acid versus human-based collagen implant in the treatment of nasolabial fold wrinklesJournal of the American Academy of Dermatology, 2010